Molecular hydrogen therapies and the benefits for menopausal and perimenopausal women: An aphoristic review

Abstract

Women account for half of the global population, yet, when applying of the principles of legislation to women's health and gender-based research there is a void pertaining to women-specific healthcare as they age. Hydrogen therapies such as oxy-hydrogen (HHO, H2/O2) inhalation act as a novel, non-toxic, antioxidant and anti-inflammatory compounds, with clinical and empirical research confidently suggesting such therapies may be beneficial to human reproductive health. This aphoristic review highlights the need for medical evidence-based research into female-focused age conditioning and offers an explanation as to why HHO therapies may be effective in combatting menopausal and perimenopausal symptoms.

The effect of hydrogen-rich water consumption on premenstrual symptoms and quality of life: a randomized controlled trial

“…Another action mechanism reported that H 2 acts similarly to estrogen derivatives by upregulating the endogenous expression of antioxidant enzymes and peptides as an antioxidant [ 32 ]. During the late luteal phase of the menstrual cycle, estrogen hormone levels are low in preparation for menstruation.…”